Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Azahomoaminopterin, a New Type of Folic Acid Antimetabolite

K. SLAVÍK, V. SLAVÍKOVÁ, K. MOTYČKA, E. HERMANOVÁ, J. SOUČEK, Z. TOMSOVÁ, M. ŠPUNDOVÁ and E. NOVÁKOVÁ
Molecular Pharmacology March 1969, 5 (2) 137-147;
K. SLAVÍK
Laboratory of Protein Metabolism, School of Medicine, Charles’ University, and Institute of Hematology and Blood Transfusion, Prague, Czechoslovakia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V. SLAVÍKOVÁ
Laboratory of Protein Metabolism, School of Medicine, Charles’ University, and Institute of Hematology and Blood Transfusion, Prague, Czechoslovakia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. MOTYČKA
Laboratory of Protein Metabolism, School of Medicine, Charles’ University, and Institute of Hematology and Blood Transfusion, Prague, Czechoslovakia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. HERMANOVÁ
Laboratory of Protein Metabolism, School of Medicine, Charles’ University, and Institute of Hematology and Blood Transfusion, Prague, Czechoslovakia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. SOUČEK
Laboratory of Protein Metabolism, School of Medicine, Charles’ University, and Institute of Hematology and Blood Transfusion, Prague, Czechoslovakia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Z. TOMSOVÁ
Laboratory of Protein Metabolism, School of Medicine, Charles’ University, and Institute of Hematology and Blood Transfusion, Prague, Czechoslovakia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. ŠPUNDOVÁ
Laboratory of Protein Metabolism, School of Medicine, Charles’ University, and Institute of Hematology and Blood Transfusion, Prague, Czechoslovakia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E. NOVÁKOVÁ
Laboratory of Protein Metabolism, School of Medicine, Charles’ University, and Institute of Hematology and Blood Transfusion, Prague, Czechoslovakia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

Several new folic acid and aminopterin analogues were synthesized, in which the aliphatic chain binding the pteridine and aromatic nucleus was extended by 1 nitrogen atom. Condensation of 2-amino-4-hydroxypteridine-6-aldehyde with p-hydrazinobenzoylglutamate gave a hydrazone whose carbon-nitrogen double bond was reduced by sodium borohydride to form 11-azahomofolic acid. 11-Azahomopteroic acid was prepared by the condensation of 2-amino-4-hydroxypteridine-6-aldehyde with p-hydrazinobenzoic acid and subsequent reduction of the hydrazone with sodium borohydride. 11-Azahomoaminopterin and 4-aminoazahomopteroic acid were prepared in the same manner, using 2,4-diaminopteridine-6-aldehyde as the starting compound. The 5,6,7,8-tetrahydro derivatives of azahomofolic acid and azahomoaminopterin were prepared by catalytic hydrogenation of the parent compounds in glacial acetic acid.

Azahomopteroic acid and related compounds showed no significant inhibitory effect on HeLa cells grown in tissue culture, or any toxicity for mice in doses up to 100 mg/kg. Azahomoaminopterin, its parent hydrazone, and analogous pteroic acid derivatives exhibited a marked cytostatic effect on HeLa cells and were toxic for mice in doses exceeding 100 mg/kg, whereas 4-aminoazahomopteroic acid and its parent hydrazone showed no toxicity when administered in the same doses.

Among the enzymes interconverting folic acid or involving tetrahydrofolate as a coenzyme, thymidylate synthetase was inhibited slightly by azahomoaminopterin and more strongly by its tetrahydro derivative, the inhibition being noncompetitive versus tetrahydrofolate.

Folate reductase from mouse liver was inhibited by all the analogues containing an NH2 group in position 4 (azahomoaminopterin and related substances). Azahomofolic acid and its derivatives were ineffective. Other tetrahydrofolate-interconverting enzyme systems and purine biosynthesis were not inhibited by any of the compounds studied.

  • Copyright ©, 1969, by Academic Press Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 5, Issue 2
1 Mar 1969
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Azahomoaminopterin, a New Type of Folic Acid Antimetabolite
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Azahomoaminopterin, a New Type of Folic Acid Antimetabolite

K. SLAVÍK, V. SLAVÍKOVÁ, K. MOTYČKA, E. HERMANOVÁ, J. SOUČEK, Z. TOMSOVÁ, M. ŠPUNDOVÁ and E. NOVÁKOVÁ
Molecular Pharmacology March 1, 1969, 5 (2) 137-147;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Azahomoaminopterin, a New Type of Folic Acid Antimetabolite

K. SLAVÍK, V. SLAVÍKOVÁ, K. MOTYČKA, E. HERMANOVÁ, J. SOUČEK, Z. TOMSOVÁ, M. ŠPUNDOVÁ and E. NOVÁKOVÁ
Molecular Pharmacology March 1, 1969, 5 (2) 137-147;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Relapsed-Leukemia Model with NT5C2/PRPS1 Hotspot Mutations
  • The Binding Site for KCI807 in the Androgen Receptor
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics